Our working hypothesis was that the MSCs would promote neovascularization, which would be potentiated by high VEGF expression and contribute to the Aβ peptide clearance, consequently improving the cognitive deficits that are present in AD. This evidence concerns the gene VEGFA and Alzheimer disease.